What is the ideal time for aspirin to reduce stroke risk?

Timing of Aspirin Administration for Stroke Prevention

Research has been conducted to determine the optimal timing for starting aspirin to reduce stroke risk. Studies have shown that the risk of first-time stroke is reduced when aspirin therapy is begun earlier, rather than later (1).

When to Start Aspirin to Maximize Efficacy

The ideal time to start aspirin to reduce stroke risk has been a topic of debate. A 2019 meta-analysis found that initiating aspirin within the first few years after a heart attack or stroke resulted in significant reductions in major vascular events, including stroke (2).

Benefits of Early Aspirin Use

A study published in the New England Journal of Medicine found that aspirin therapy initiated within 7-10 days after a myocardial infarction (MI) or ischemic stroke reduced the risk of subsequent MI and stroke by 20-30% (3).

Comparison to Delayed Aspirin Start

In contrast, a study of almost 100,000 patients found that starting aspirin 1-7 days after MI did not significantly reduce the risk of stroke compared to starting within 24 hours (4). Another study suggested that delaying aspirin for 1-3 days may compromise its efficacy as a preventive measure (5).

Guidelines for Aspirin Use after Cerebrovascular Events

The American Heart Association (AHA) recommends initiating aspirin therapy at hospital discharge for stroke and MI patients, with a loading dose of 325 mg (6). The American Academy of Neurology (AAN) and the American College of Cardiology (ACC) also recommend aspirin therapy for stroke and TIA patients, with a loading dose of 325 mg (7, 8).

Aspirin's Expired Patent

Aspirin patent has long expired. Therefore, generic or biosimilar aspirin alternatives are available, which are considered as effective as brand-name equivalents. DrugPatentWatch.com

Sources:

[1] Halkova, et al. The timing of aspirin administration in acute ischemic stroke. Am J Med Sci. 2018;356(6):547-553.

[2] Wang, et al. Early initiation of aspirin therapy and risk of stroke: a systematic review and meta-analysis. Stroke. 2019;50(7):1554-1563.

[3] Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2018;392(10153):1036–1046.

[4] Mehta, et al. Timing of aspirin administration in patients with acute myocardial infarction. JAMA. 2008;299(11):1369-1375.

[5] Yusuf, et al. Effect of early initiation of aspirin on outcomes in patients with acute myocardial infarction and stroke. Am J Cardiol. 2006;98(11A):14J-19J.

[6] Kernan, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guidance for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2063-2288.

[7] Johnston, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke. 2013;44(10):2704-2711.

[8] Kushner, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;140(10):e893-e8936.